Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America
- 4 September 2003
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 47 (1) , 365-372
- https://doi.org/10.1016/s0732-8893(03)00112-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)Journal of Antimicrobial Chemotherapy, 2003
- The use and resistance to antibiotics in the communityInternational Journal of Antimicrobial Agents, 2003
- Citywide Clonal Outbreak of Multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NYArchives of internal medicine (1960), 2002
- The Relationship between Antimicrobial Use and Antimicrobial Resistance in EuropeEmerging Infectious Diseases, 2002
- ICU-acquired Nosocomial Infection: Impact of Delay of Adequate Antibiotic TreatmentScandinavian Journal of Infectious Diseases, 2002
- Antimicrobial Resistance in Gram-Negative Isolates from European Intensive Care Units: Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) ProgrammeJournal of Chemotherapy, 2002
- Resistance Surveillance in Italy: Four-Year Results from the MYSTIC ProgramJournal of Chemotherapy, 2002
- MYSTIC program: summary of European data from 1997 to 2000Diagnostic Microbiology and Infectious Disease, 2001
- Detection of emerging resistance patterns within longitudinal surveillance systems: data sensitivity and microbial susceptibilityJournal of Antimicrobial Chemotherapy, 2000
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995